✦ LIBER ✦

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

✍ Scribed by X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. Corzo; L. Fernandez-Novoa; M. Vargas; M. Aleixandre; C. Linares; E. Granizo; D. Muresanu; H. Moessler

Book ID: 111064607
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 309 KB
Volume: 13
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2006.01222.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of Cerebrolysin in m

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

✍ X. A. Alvarez; R. Cacabelos; C. Sampedro; M. Aleixandre; C. Linares; E. Granizo; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

A long-term, double-blind, placebo-contr

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

Melissa officinalis extract in the treat

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

Saffron in the treatment of patients wit

Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial

✍ S. Akhondzadeh; M. Shafiee Sabet; M. H. Harirchian; M. Togha; H. Cheraghmakani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

A double-blind, placebo-controlled, enri

A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease

✍ F. Forette; T. Hoover; S. Gracon; J. de Rotrou; M.P. Hervy; B. Lechevalier; M. M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 973 KB